Structures by: Essassi E. M.

Total: 358

Dimethyl 3-acetyl-3-(1,3-benzothiazol-2-yl)pentanedioate

C16H17NO5S

Baryala, YamnaSalem, MoussaEssassi, El MokhtarReuter, HansIzaaryene, Maher

Acta Crystallographica Section E (2008) 64, 12 o2290

a=14.4075(3)Å   b=8.8089(2)Å   c=13.8968(3)Å

α=90.00°   β=118.0110(10)°   γ=90.00°

6-Methyl-7,7,9-tripropargyl-7<i>H</i>-1,2,4- triazolo[4,3-<i>b</i>][1,2,4]triazepin-8(9<i>H</i>)-one

C15H13N5O

Zemama, Redwan MohamedAmari, IbtissamBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 9 o2148

a=7.6710(2)Å   b=8.2415(2)Å   c=12.9619(3)Å

α=108.5100(10)°   β=90.6590(10)°   γ=114.7260(10)°

1-Benzyl-3-[(dimethylamino)methylene]-4-phenyl-1<i>H</i>- 1,4-benzodiazepin-2(3<i>H</i>)-one

C25H23N3O

Zemama, Redwan MohamedAmari, IbtissamBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 9 o2160

a=8.9733(3)Å   b=26.3103(7)Å   c=9.9312(3)Å

α=90°   β=115.6440(10)°   γ=90°

7,9-Diallyl-6-methyl-7<i>H</i>-1,2,4-triazolo[4,3-<i>b</i>][1,2,4]triazepin-\ 8(9<i>H</i>)-one

C12H15N5O

Zemama, Redwan MohamedAmari, IbtissamBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 9 o2152

a=7.4674(3)Å   b=8.3398(3)Å   c=20.2214(6)Å

α=90.00°   β=95.174(2)°   γ=90.00°

3-Methyl-1-propargylquinoxalin-2(1<i>H</i>)-one

C12H10N2O

Benzeid, HananeRamli, YoussefVendier, LaureEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 9 o2196

a=21.1240(10)Å   b=4.3709(2)Å   c=22.2460(10)Å

α=90.00°   β=105.354(6)°   γ=90.00°

5-Methyl-3-[1-(2-pyridylmethyl)-1<i>H</i>-benzimidazol-2-ylmethyl]isoxazole

C18H16N4O

Doumbia, Mohamadou LamineBouhfid, RachidEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2009) 65, 11 o2714-o2715

a=11.0761(2)Å   b=8.65350(10)Å   c=16.5920(3)Å

α=90.0°   β=103.1360(10)°   γ=90.0°

3-[2-(3-Methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)ethyl]oxazolidin-2-one

C14H15N3O3

Caleb, Ahoya AnothaneBouhfid, RachidEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2009) 65, 8 o2024-o2025

a=12.280(3)Å   b=10.736(3)Å   c=20.406(4)Å

α=90°   β=102.320(10)°   γ=90°

1-Allyl-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one

C18H16N2O

Ballo, DaoudaAhabchane, Noureddine HamouZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1277

a=11.4863(3)Å   b=6.0053(2)Å   c=20.3667(5)Å

α=90.00°   β=93.5250(10)°   γ=90.00°

1-(1-Nonyl-2-oxoindolin-3-ylidene)thiosemicarbazide

C18H26N4OS

Mamari, KhalilZerzouf, AbdelfettahZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1332

a=11.5343(2)Å   b=10.5921(2)Å   c=15.6262(3)Å

α=90.00°   β=95.9220(10)°   γ=90.00°

1-(1-Decyl-2-oxoindolin-3-ylidene)thiosemicarbazide

C19H28N4OS

Mamari, KhalilZerzouf, AbdelfettahZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1333

a=11.8856(2)Å   b=11.0055(2)Å   c=15.1638(3)Å

α=90.00°   β=99.4680(10)°   γ=90.00°

1-Tetradecylindoline-2,3-dione

C22H33NO2

Mamari, KhalilZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1410

a=27.6647(8)Å   b=4.70550(10)Å   c=15.7583(5)Å

α=90.00°   β=103.6350(10)°   γ=90.00°

1-Decylindoline-2,3-dione

C18H25NO2

Mamari, KhalilZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1411

a=22.7208(3)Å   b=4.71890(10)Å   c=15.82540(10)Å

α=90.00°   β=106.8270(10)°   γ=90.00°

Ethyl {4-[(1,5-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5- benzodiazepin-3-yl)methyl]-1,2,3-triazol-1-yl}acetate

C18H21N5O4

Dardouri, RachidaKandri Rodi, YoussefLadeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 11 o3039

a=8.5452(2)Å   b=15.9993(5)Å   c=13.9215(4)Å

α=90.00°   β=106.8530(10)°   γ=90.00°

3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-6-bromo-2-phenyl- 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine

C22H17BrN6

Ouzidan, YounesKandri Rodi, YoussefFronczek, Frank R.Venkatraman, RamaiyerEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 4 o890-o891

a=41.122(6)Å   b=5.8358(10)Å   c=15.988(3)Å

α=90°   β=93.922(6)°   γ=90°

Methyl 2-(3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl)acetate

C11H11NO3S

Barryala, YamnaMassip, StéphaneLazar, SaïdEssassi, El MokhtarZouihri, Hafid

Acta Crystallographica Section E (2011) 67, 3 o724

a=17.347(5)Å   b=8.724(2)Å   c=7.2740(10)Å

α=90.00°   β=98.71(2)°   γ=90.00°

1,3-Dimethyl-3-tetradecyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

C25H40N2O2

Dardouri, RachidOuazzani Chahdi, FouadSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 3 o674

a=8.12860(10)Å   b=33.5899(5)Å   c=9.4095(2)Å

α=90.00°   β=114.6400(10)°   γ=90.00°

3-{[3-(4-Chlorophenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}-1,5-dimethyl- 1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

C21H20ClN3O3

Dardouri, RachidaRodi, Youssef KandriLadeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 3 o720

a=8.18210(10)Å   b=9.07410(10)Å   c=13.3792(2)Å

α=79.7480(10)°   β=80.1420(10)°   γ=85.9100(10)°

5-Nitro-1-nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C16H23N3O3

Ouzidan, YounesKandri Rodi, YoussefEssassi, El MokhtarEl Ammari, LahcenFronczek, Frank R.Venkatraman, Ramaiyer

Acta Crystallographica Section E (2011) 67, 3 o669

a=5.4830(10)Å   b=10.2092(15)Å   c=14.746(3)Å

α=74.275(9)°   β=79.727(6)°   γ=83.410(8)°

3-[2-(3-Methylquinoxalin-2-yloxy)ethyl]-1,3-oxazolidin-2-one

C14H15N3O3

Ahoya, Caleb AnothaneBouhfid, RachidDaouda, BalloEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2010) 66, 5 o1050

a=6.9936(3)Å   b=7.6916(3)Å   c=13.3709(6)Å

α=86.649(2)°   β=77.044(2)°   γ=71.141(2)°

(<i>E</i>)-4-(2,3-Dihydro-1,3-benzothiazol-2-ylidene)-3-methyl-1-phenyl- 1<i>H</i>-pyrazol-5(4<i>H</i>)-one

C17H13N3OS

Chakibe, ImaneZerzouf, AbdelfettahEssassi, El MokhtarReichelt, MartinReuter, Hans

Acta Crystallographica Section E (2010) 66, 5 o1096

a=27.0144(8)Å   b=7.4021(2)Å   c=14.0523(4)Å

α=90.00°   β=97.4660(10)°   γ=90.00°

3-Methyl-1-(prop-2-en-1-yl)quinoxalin-2(1<i>H</i>)-one

C12H12N2O

Ramli, YoussefSlimani, RachidZouihri, HafidLazar, SaïdEssassi, E. M.

Acta Crystallographica Section E (2010) 66, 7 o1767

a=5.0722(5)Å   b=13.4707(13)Å   c=15.0507(13)Å

α=90.00°   β=95.082(5)°   γ=90.00°

3-[2-(5<i>H</i>-Indolo[2,3-<i>b</i>]quinoxalin-5-yl)ethyl]-1,3-oxazolidin-2-one

C19H16N4O2

Alsubari, AbdussalamBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 9 o2461

a=14.5565(4)Å   b=5.8993(2)Å   c=18.6434(6)Å

α=90.00°   β=92.393(2)°   γ=90.00°

1-Nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C16H24N2O

Ouzidan, YounesKandri Rodi, YoussefButcher, Raymond J.Essassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 2 o283

a=18.0230(10)Å   b=5.4585(2)Å   c=16.5708(9)Å

α=90.00°   β=115.543(7)°   γ=90.00°

1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-1<i>H</i>-benzimidazol- 2(3<i>H</i>)-one

C17H20N4O5

Ouzidan, YounesKandri Rodi, YoussefFronczek, Frank R.Venkatraman, RamaiyerEl Ammari, LahcenEssassi, El Mokhtar

Acta Crystallographica Section E (2011) 67, 2 o362-o363

a=10.5331(10)Å   b=10.9647(10)Å   c=14.5541(14)Å

α=90°   β=103.258(5)°   γ=90°

4-Phenyl-9,12,15-trioxa-1,5,6,18- tetraazatetracyclo[16.6.1.0^2,6^.0^19,24^]pentaconta-2,4,19,21,23- pentaen-25-one

C24H26N4O4

Ghomsi, Joseph NathanAhabchane, Noureddine HamouBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 10 o2493

a=13.3480(10)Å   b=15.7850(10)Å   c=11.0070(10)Å

α=90°   β=102.6810(10)°   γ=90°

1,3-Diallyl-2-methylbenzimidazolium bromide dihydrate

C14H17N2,Br,2H2O

Ennajih, HamidBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 10 o2321

a=13.2888(2)Å   b=16.8763(2)Å   c=7.38970(10)Å

α=90.00°   β=109.7730(10)°   γ=90.00°

\ 10-Allyl-2,3-dihydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,\ 11(10<i>H</i>,11a<i>H</i>)-dione

C15H16N2O2

Benzeid, HananeEssassi, El MokhtarSaffon, NathalieGarrigues, BernardNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 10 o2322

a=7.09880(10)Å   b=11.7166(2)Å   c=15.6592(3)Å

α=90.00°   β=90.00°   γ=90.00°

1-Methyl-3-phenylquinoxalin-2(1<i>H</i>)-one

C15H12N2O

Benzeid, HananeEssassi, El MokhtarSaffon, NathalieGarrigues, BernardNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 10 o2323

a=16.3919(5)Å   b=7.0775(2)Å   c=20.0214(6)Å

α=90.00°   β=95.434(2)°   γ=90.00°

1-Allyl-3-chloro-6-nitro-1<i>H</i>-indazole

C10H8ClN3O2

El Brahmi, NabilMohamed, BenchidmiEssassi, El MokhtarZouihri, HafidNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 10 o2320

a=7.68040(10)Å   b=9.9559(2)Å   c=28.4344(4)Å

α=90°   β=95.1440(10)°   γ=90°

1-Benzyl-3-phenylquinoxalin-2(1<i>H</i>)-one

C21H16N2O

Benzeid, HananeSaffon, NathalieGarrigues, BernardEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 11 o2685

a=5.4776(2)Å   b=12.7015(3)Å   c=12.7469(4)Å

α=62.260(2)°   β=89.963(2)°   γ=87.845(2)°

10,10'-Methylenebis[2,3-dihydro-1<i>H</i>- benzo[<i>e</i>]pyrrolo[1,2-<i>a</i>][1,4]diazepine- 5,11(10<i>H</i>,11a<i>H</i>)-dione] dihydrate

C25H24N4O4,2(H2O)

Benzeid, HananeSaffon, NathalieGarrigues, BernardEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 11 o2684

a=11.9901(2)Å   b=11.9901Å   c=13.6054(2)Å

α=90°   β=90°   γ=120°

1-Acetyl-4-phenyl-5a,6,7,8,9,9a-hexahydro-5<i>H</i>- 1,5-benzodiazepin-2(1<i>H</i>)-one

C17H20N2O2

Benzeid, HananeSaffon, NathalieGarrigues, BernardEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2009) 65, 11 o2657

a=9.6794(2)Å   b=14.0095(3)Å   c=11.2832(2)Å

α=90°   β=98.0530(10)°   γ=90°

4-[(1,5-Dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin- 3-yl)methyl]-1-<i>n</i>-octyl-1<i>H</i>-1,2,3-triazole

C34H39N5O2

Jabli, HindOuazzani Chahdi, F.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 1 o231

a=9.1797(2)Å   b=10.4238(2)Å   c=31.4716(7)Å

α=90.00°   β=90.00°   γ=90.00°

1-(12-Azido-<i>n</i>-dodecyl)-4-[(1,5-dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-\ 1<i>H</i>-1,5-benzodiazepin-3-yl)methyl]-1<i>H</i>-1,2,3-triazole

C38H46N8O2

Jabli, HindOuazzani Chahdi, F.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 1 o232

a=9.4269(2)Å   b=12.3304(3)Å   c=15.5500(4)Å

α=101.121(2)°   β=92.175(2)°   γ=92.935(2)°

Ethyl 2-{4-[(1,5-dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5- benzodiazepin-3-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate

C30H29N5O4

Jabli, HindKandri Rodi, Y.Ladeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 1 o126

a=14.2015(5)Å   b=10.9337(4)Å   c=17.9368(6)Å

α=90.00°   β=95.699(2)°   γ=90.00°

3-[2-(2,3-dioxoindolin-1-yl)ethyl]-1,3-oxazolidin-2-one

C13H12N2O4

Al Subari, AbdusalamBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 2 o454

a=7.1198(2)Å   b=7.4694(2)Å   c=12.0319(3)Å

α=83.338(2)°   β=79.084(2)°   γ=81.372(2)°

1,3-Dibenzyl-2-methylbenzimidazolium chloride

C22H21N2,Cl

Ennajih, HamidBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 2 o455

a=9.2539(2)Å   b=9.4677(2)Å   c=12.0984(3)Å

α=72.1390(10)°   β=81.3760(10)°   γ=64.6050(10)°

6-Bromo-1-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-1<i>H</i>- imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C11H11BrN4O3

Bel-Ghacham, H.Kandri Rodi, Y.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 2 o456

a=27.0174(11)Å   b=6.0141(2)Å   c=16.6121(6)Å

α=90.00°   β=110.343(2)°   γ=90.00°

3-(Phenylimino)indolin-2-one

C14H10N2O

Al Subari, AbdusalamBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 2 o453

a=20.1647(4)Å   b=5.02230(10)Å   c=21.8791(5)Å

α=90.00°   β=90.00°   γ=90.00°

3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1,5-dimethyl- 1,5-benzodiazepine-2,4-dione

C21H21N5O2

Dardouri, R.Kandri Rodi, Y.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 3 o632

a=8.3380(3)Å   b=9.1033(3)Å   c=13.4796(4)Å

α=95.385(2)°   β=107.840(2)°   γ=101.768(2)°

3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-1,5-dimethyl- 1,5-benzodiazepine-2,4-dione monohydrate

C21H21N5O2,H2O

Dardouri, R.Kandri Rodi, Y.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 3 o633

a=9.60020(10)Å   b=11.9497(2)Å   c=17.0860(2)Å

α=90.00°   β=92.5270(10)°   γ=90.00°

2-Hydroxy-10-propargylpyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,11-dione monohydrate

C15H14N2O3,H2O

Ourahou, S.Chammache, M.Zouihri, H.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o731

a=6.89770(10)Å   b=7.97610(10)Å   c=13.0680(2)Å

α=90.00°   β=99.1940(10)°   γ=90.00°

2-Hydroxy-10-phenacylpyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,11-dione

C20H18N2O4

Ourahou, S.Chammache, M.Zouihri, H.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o732

a=8.8337(2)Å   b=9.9476(2)Å   c=18.9295(4)Å

α=90.00°   β=90.00°   γ=90.00°

Ethyl 2-hydroxy-5,11-dioxopyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-10-acetate

C16H18N2O5

Ourahou, S.Chammache, M.Zouihri, H.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o733

a=8.5503(2)Å   b=9.6580(2)Å   c=18.2734(4)Å

α=90.00°   β=90.00°   γ=90.00°

2-Methyl-3-(<i>n</i>-octylsulfanyl)quinoxaline

C17H24N2S

Ramli, YoussefSlimani, RachidZouihri, HafidLazar, SaïdEssassi, E. M.

Acta Crystallographica Section E (2010) 66, 4 o992

a=7.3514(3)Å   b=8.2978(3)Å   c=14.2168(5)Å

α=92.275(2)°   β=98.706(2)°   γ=103.810(2)°

<i>N</i>-(5-Phenyl-1<i>H</i>-pyrazol-3-yl)benzene-1,2-diamine

C15H14N4

Doumbia, Mohamadou LamineBouhfid, RachidEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2010) 66, 4 o841

a=13.2357(8)Å   b=5.8473(4)Å   c=16.4039(10)Å

α=90.00°   β=92.074(4)°   γ=90.00°

6-Bromo-1-(1,2-propadienyl)-3-(2-propynyl)-1<i>H</i>- imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C12H8BrN3O

Dahmani, S.Haoudi, A.Capet, F.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o755

a=9.6369(4)Å   b=9.3086(4)Å   c=13.5481(5)Å

α=90.00°   β=99.123(2)°   γ=90.00°

6-Bromo-1,3-di-2-propynyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 2(3<i>H</i>)-one

C12H8BrN3O

Dahmani, S.Haoudi, A.Capet, F.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o756

a=9.0725(3)Å   b=18.6212(5)Å   c=7.0684(2)Å

α=90.00°   β=102.9950(10)°   γ=90.00°

3-(Benzothiazol-2-yl)-3-(prop-2-ynyl)hex-5-yn-2-one

C16H13NOS

Baryala, YamnaZerzouf, AbdelfettahSalem, MoussaEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2010) 66, 4 o857

a=7.79130(10)Å   b=30.2051(6)Å   c=12.4437(2)Å

α=90.00°   β=106.1610(10)°   γ=90.00°

4-Benzyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine

C19H14BrN3

Ouzidan, Y.Obbade, S.Capet, F.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o946

a=8.6613(6)Å   b=19.7631(13)Å   c=9.3683(6)Å

α=90.00°   β=99.647(3)°   γ=90.00°

4-Benzyl-6-bromo-2-(4-methoxyphenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate

C20H16BrN3O,H2O

Ouzidan, Y.Kandri Rodi, Y.Obbade, S.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o947

a=10.5924(2)Å   b=5.45440(10)Å   c=31.7444(7)Å

α=90.00°   β=100.2920(10)°   γ=90.00°

6-Bromo-3-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C7H6BrN3O

Ghacham, Hend BelRodi, Youssef KandriCapet, FrédéricEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 5 o1080

a=4.41510(10)Å   b=9.6004(2)Å   c=10.5330(3)Å

α=116.2480(10)°   β=93.074(2)°   γ=91.6870(10)°

1-Benzyl-3-[(dimethylamino)methylene]-4-phenyl-1<i>H</i>-1,5-benzodiazepine- 2(3<i>H</i>)-thione

C25H23N3S

Ballo, DaoudaBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 5 o1019

a=26.4740(8)Å   b=10.2366(2)Å   c=16.5650(5)Å

α=90.00°   β=106.1360(10)°   γ=90.00°

8-Bromo-3,4-dihydro-2<i>H</i>1,3-thiazino[2,3:2',1']imidazo[5',4'- <i>b</i>]pyridine

C9H8BrN3S

Ghacham, Hend BelRodi, Youssef KandriCapet, FrédéricEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 5 o1079

a=20.2738(3)Å   b=13.2786(2)Å   c=7.31690(10)Å

α=90.00°   β=102.1930(10)°   γ=90.00°

3,4-Dimethyl-1<i>H</i>-1,2,4-triazepino[2,3-<i>a</i>]benzimidazol- 2(3<i>H</i>)-one

C12H12N4O

Saber, AsmaeAl Subari, AbdusalamZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 5 o1093

a=7.2899(3)Å   b=14.4888(5)Å   c=10.9932(4)Å

α=90.00°   β=104.3140(10)°   γ=90.00°

1-Isopropenyl-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one

C10H10N2O

Saber, AsmaaZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1409

a=15.8724(2)Å   b=6.09710(10)Å   c=17.9313(3)Å

α=90.00°   β=90.961(2)°   γ=90.00°

4-Methyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one monohydrate

C10H10N2O,H2O

Saber, AsmaaZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 6 o1408

a=4.90130(10)Å   b=7.31480(10)Å   c=13.5688(2)Å

α=85.3750(10)°   β=83.9590(10)°   γ=83.8070(10)°

3-Benzyl-6-bromo-2-(2-furyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine

C17H12BrN3O

Ouzidan, YounèsRodi, Youssef KandriZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 7 o1874

a=15.8422(3)Å   b=5.47470(10)Å   c=18.4243(3)Å

α=90.00°   β=111.5090(10)°   γ=90.00°

1,5-Dimethyl-3-propargyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

C14H14N2O2

Dardouri, RachidOuazzani Chahdi, F.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 7 o1797

a=16.0768(3)Å   b=17.1087(3)Å   c=8.9530(2)Å

α=90.00°   β=93.7010(10)°   γ=90.00°

Pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,11-dithione

C12H12N2S2

Ourahou, SarahZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 7 o1653

a=13.9831(5)Å   b=10.0134(3)Å   c=8.2670(3)Å

α=90.00°   β=97.0890(10)°   γ=90.00°

4-Allyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate

C15H12BrN3,H2O

Ouzidan, YounèsRodi, Youssef KandriZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o1903

a=7.43630(10)Å   b=9.42380(10)Å   c=11.0829(2)Å

α=68.0760(10)°   β=74.6370(10)°   γ=79.7360(10)°

6-Bromo-1,3-dimethyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C8H8BrN3O

Dahmani, SihamRodi, Youssef KandriZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o1904

a=21.7981(4)Å   b=3.99290(10)Å   c=20.6636(3)Å

α=90.00°   β=95.3980(10)°   γ=90.00°

<i>N</i>'-(1-Allyl-2-oxoindolin-3-ylidene)benzohydrazide

C18H15N3O2

Alsubari, AbdulsalamMoussaif, AhmedZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o1905

a=7.5921(2)Å   b=15.1968(4)Å   c=12.8716(3)Å

α=90.00°   β=94.481(2)°   γ=90.00°

1-Benzyl-3-methylquinoxalin-2(1<i>H</i>)-one

C16H14N2O

Ramli, YoussefMoussaif, AhmedZouihri, HafidLazar, SaïdEssassi, E. M.

Acta Crystallographica Section E (2010) 66, 8 o1922

a=7.4433(2)Å   b=17.5444(5)Å   c=18.0598(7)Å

α=118.034(2)°   β=100.217(2)°   γ=92.7260(10)°

Ethyl 2-(2-oxo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-1-yl)acetate

C19H18N2O3

Ballo, DaoudaAhabchane, Noureddine HamouZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o2070

a=12.5198(4)Å   b=11.7911(3)Å   c=11.2058(3)Å

α=90.00°   β=97.843(2)°   γ=90.00°

1-[2-(2-Oxo-1,3-oxazolidin-3-yl)ethyl]-4-phenyl-1<i>H</i>- 1,5-benzodiazepin-2(3<i>H</i>)-one

C20H19N3O3

Ballo, DaoudaAhabchane, Noureddine HamouZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o2080

a=9.0163(5)Å   b=11.6671(6)Å   c=16.2019(8)Å

α=90.00°   β=90.00°   γ=90.00°

1,5-Dimethyl-3-[(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)methyl]- 1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

C21H21N3O3

Dardouri, RachidaKandri Rodi, YoussefSaffon, NathalieEl Ammari, LahcenEssassi, El Mokhtar

Acta Crystallographica Section E (2010) 66, 11 o2983

a=9.3491(2)Å   b=6.97220(10)Å   c=27.9201(5)Å

α=90.00°   β=93.1570(10)°   γ=90.00°

4-(1,3-Benzothiazol-2-yl)-5-methyl-2-phenyl-1-propynyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one

C20H15N3OS

Chakib, ImaneZerzouf, AbdelfettahZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 11 o2843

a=4.82210(10)Å   b=9.3698(2)Å   c=37.6990(9)Å

α=90.00°   β=90.00°   γ=90.00°

3-(6-Bromohexyl)-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

C17H23BrN2O2

Dardouri, RchidaOuazzani Chahdi, FouadSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 11 o2804

a=7.52140(10)Å   b=9.3693(2)Å   c=23.8686(5)Å

α=90.00°   β=91.7500(10)°   γ=90.00°

3-(12-Bromododecyl)-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

C23H35BrN2O2

Dardouri, RchidaOuazzani Chahdi, FouadSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 11 o2805

a=7.59710(10)Å   b=10.5032(2)Å   c=28.7129(5)Å

α=90.00°   β=95.2130(10)°   γ=90.00°

1-Allyl-4-(1,3-benzothiazol-2-yl)-5-methyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one

C20H17N3OS

Chakib, ImaneZerzouf, AbdelfettahZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 11 o2842

a=17.8734(5)Å   b=10.4297(2)Å   c=18.9578(4)Å

α=90.00°   β=90.00°   γ=90.00°

3-[2-(1<i>H</i>-Benzimidazol-2-ylsulfanyl)ethyl]-1,3-oxazolidin-2-one

C12H13N3O2S

Moussaif, AhmedEssassi, El MokhtarLazar, SaidZouihri, HafidLeger, Jean Michel

Acta Crystallographica Section E (2010) 66, 12 o3137

a=8.2580(10)Å   b=10.0740(10)Å   c=29.201(3)Å

α=90.00°   β=90.00°   γ=90.00°

7-Chloro-1,5-dipropargyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

C15H11ClN2O2

Dardouri, RachidKandri Rodi, YoussefSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 12 o3228

a=10.7755(3)Å   b=7.6580(2)Å   c=16.7221(5)Å

α=90.00°   β=103.6210(10)°   γ=90.00°

1-Allyl-3-methyl-3',5'-diphenylspiro[quinoxaline- 2(1<i>H</i>),2'(3'<i>H</i>)-[1,3,4]thiadiazole]

C25H22N4S

Anothane, Caleb AhoyaBouhfid, RachidZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 12 o3227

a=7.92010(10)Å   b=10.07130(10)Å   c=13.6642(2)Å

α=78.2960(10)°   β=81.2770(10)°   γ=89.8260(10)°

1,3-Diallyl-5-chloro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C13H13ClN2O

Ouzidan, YounesKandri Rodi, Y.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 2 o520

a=7.88310(10)Å   b=15.2481(3)Å   c=10.3593(2)Å

α=90.00°   β=93.0560(10)°   γ=90.00°

1,3,3,5-Tetramethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

C13H16N2O2

Dardouri, RachidaRodi, Youssef KandriSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 4 o783

a=7.51120(10)Å   b=10.1731(2)Å   c=15.8697(3)Å

α=90.00°   β=103.6750(10)°   γ=90.00°

3-Benzoyl-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-\ dione

C18H16N2O3

Dardouri, RachidaRodi, Youssef KandriLadeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 4 o849

a=7.78270(10)Å   b=23.7595(4)Å   c=8.6315(2)Å

α=90.00°   β=105.6140(10)°   γ=90.00°

5-Nitro-1-<i>n</i>-octyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C15H21N3O3

Ouzidan, YounesKandri Rodi, Y.Saffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 3 o558

a=4.9997(3)Å   b=11.4942(6)Å   c=13.8739(7)Å

α=74.214(3)°   β=79.637(4)°   γ=84.108(4)°

1-<i>n</i>-decyl-5-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C17H25N3O3

Ouzidan, YounesKandri Rodi, Y.Ladeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 3 o613

a=5.4933(2)Å   b=10.3063(4)Å   c=16.1655(6)Å

α=106.504(2)°   β=98.545(2)°   γ=96.809(2)°

<i>rac</i>-(3<i>S</i>,4<i>S</i>)-3-Hydroxy-4-phenyl-1-[(<i>S</i>)-(3-phenyl- 4,5-dihydro-1,2-oxazol-5-yl)methyl]-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one

C25H23N3O3

Rida, MohamedEssassi, El MokhtarMassip, StéphaneLazar, SaïdZouihri, Hafid

Acta Crystallographica Section E (2011) 67, 4 o945-o946

a=8.981(2)Å   b=9.044(2)Å   c=13.6850(10)Å

α=95.373(10)°   β=102.433(10)°   γ=100.03(2)°

1,3-Dibenzyl-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione

C29H20N2O3

Afrakssou, ZahraKandri Rodi, YoussefCapet, FrédéricEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 5 o1253-o1254

a=8.1389(3)Å   b=12.8748(4)Å   c=21.5528(8)Å

α=90.00°   β=90.00°   γ=90.00°

3-[2-(6-Bromo-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 3-yl)ethyl]-1,3-oxazolidin-2-one

C17H15BrN4O2

Ouzidan, YounesJasinski, Jerry P.Butcher, Raymond J.Golen, James A.Essassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 5 o1095

a=11.3553(6)Å   b=11.5915(5)Å   c=12.2542(8)Å

α=90.00°   β=98.685(6)°   γ=90.00°

3-{2-[(3-Phenylquinoxalin-2-yl)oxy]ethyl}-1,3-oxazolidin-2-one

C19H17N3O3

Daouda, BalloBrelot, LydiaDoumbia, Mouhamadou LamineEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 5 o1235

a=10.1392(4)Å   b=9.1398(4)Å   c=34.8462(15)Å

α=90.00°   β=90.00°   γ=90.00°

1-allyl-3-phenylquinoxalin-2(1<i>H</i>)-one

C17H14N2O

Benzeid, HananeBouhfid, RachidMassip, StephaneLeger, Jean MichelEssassi, El Mokhtar

Acta Crystallographica Section E (2011) 67, 11 o2990

a=15.123(2)Å   b=7.0390(10)Å   c=26.405(3)Å

α=90.00°   β=95.250(10)°   γ=90.00°

1-Decyl-6-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C17H25N3O3

Ouzidan, YounesKandri Rodi, YoussefEssassi, El MokhtarLuis, Santiago V.Bolte, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 11 o2937

a=32.9827(6)Å   b=4.55881(9)Å   c=29.3435(5)Å

α=90.00°   β=109.481(2)°   γ=90.00°

1,3-Bis[2-hydroxy-2-(6-methoxy-2,2-dimethyl-3a,5,6,6a-tetrahydro-2<i>H</i>- furo[2,3-<i>d</i>][1,3]dioxol-5-yl)ethyl]-2,3-dihydro-1<i>H</i>- 1,3-benzodiazol-2-one

C27H38N2O11

Lakhrissi, BrahimMassoui, MohamedRamli, YoussefEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 2 o351

a=30.5551(8)Å   b=5.31320(10)Å   c=17.8757(5)Å

α=90.00°   β=98.267(2)°   γ=90.00°

2-Hydroxy-2,3,5,10,11,11a-hexahydro-1<i>H</i>-pyrrolo[2,1- <i>c</i>][1,4]benzodiazepine-5,11-dione

C12H12N2O3

Ourahou, SarahZouihri, HafidMassoui, MohamedEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o1906

a=4.8366(2)Å   b=25.7449(11)Å   c=8.5420(4)Å

α=90.00°   β=96.509(2)°   γ=90.00°

4-(Prop-2-ynyl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one

C11H9NOS

Sebbar, Nada KheiraZerzouf, AbdelfettahEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 6 o641

a=9.005(2)Å   b=10.889(3)Å   c=10.341(3)Å

α=90.00°   β=104.565(7)°   γ=90.00°

(2<i>Z</i>)-2-Benzylidene-4-<i>n</i>-utyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one

C19H19NOS

Sebbar, Nada KheiraEl Fal, MohammedEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 6 o686

a=8.7717(13)Å   b=8.8631(13)Å   c=12.3184(16)Å

α=88.283(9)°   β=82.302(9)°   γ=60.895(8)°

<i>N</i>'-(3-Methylquinoxalin-2-yl)-<i>N</i>'-phenylbenzohydrazide

C22H18N4O

Ramli, YoussefMoussaif, AhmedZouihri, HafidBourichi, HoudaEssassi, El Mokhtar

Acta Crystallographica Section E (2011) 67, 6 o1374

a=18.6809(12)Å   b=10.5840(8)Å   c=9.5860(6)Å

α=90.00°   β=100.108(3)°   γ=90.00°

1-Acetyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C8H6BrN3O2

Dahmani, SihamKandri Rodi, YoussefLuis, Santiago V.Essassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 6 o1375

a=4.8302(15)Å   b=9.645(3)Å   c=9.809(3)Å

α=81.542(7)°   β=85.735(7)°   γ=89.676(8)°

Ethyl 8-amino-6-bromoimidazo[1,2-<i>a</i>]pyridine-2-carboxylate

C10H10BrN3O2

Dahmani, SihamKandri Rodi, YoussefLuis, Santiago V.Essassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 6 o1390

a=8.366(2)Å   b=11.842(3)Å   c=22.743(5)Å

α=90.00°   β=98.328(6)°   γ=90.00°

6-Bromo-3-methyl-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine

C13H10BrN3

Ouzidan, YounesEssassi, El MokhtarLuis, Santiago V.Bolte, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 7 o1684

a=13.7138(4)Å   b=6.7088(2)Å   c=25.3217(7)Å

α=90.00°   β=90.00°   γ=90.00°

1,3-Dibenzyl-5-chloro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C21H17ClN2O

Dardouri, RachidaRodi, Youssef KandriLadeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o2136

a=11.0380(4)Å   b=9.2863(3)Å   c=33.2679(13)Å

α=90.00°   β=92.297(2)°   γ=90.00°

1,3-Bis[3-(1,3-dioxoisoindolin-2-yl)propyl]-1<i>H</i>- anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione

C37H26N4O7

Afrakssou, ZahraRodi, Youssef KandriCapet, FrédéricEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o2137

a=8.4278(2)Å   b=13.1258(3)Å   c=13.7966(3)Å

α=94.3590(10)°   β=92.4720(10)°   γ=105.3510(10)°

5-(Pyridin-4-ylmethyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin- 4(5<i>H</i>)-one

C11H9N5O

Alsubari, AbdulsalamRamli, YoussefEssassi, El MokhtarZouihri, Hafid

Acta Crystallographica Section E (2011) 67, 8 o1926

a=4.6371(3)Å   b=19.2731(10)Å   c=5.8593(3)Å

α=90.00°   β=102.498(2)°   γ=90.00°

1,1'-Dibenzyl-5,5''-dichloro-1,1'',2,2''-tetrahydrodispiro[indole-3,7'- [6,9]diazatricyclo[7.3.0.0^2,6^]dodecane-8',3''-indole]-2,2''-dione

C38H34Cl2N4O2

Al Mamari, KhalilEnnajih, HamidBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 6 o1664

a=12.0421(2)Å   b=16.9085(2)Å   c=15.9316(2)Å

α=90.00°   β=101.2430(10)°   γ=90.00°

1-Phenyl-3<i>H</i>-2,3-benzodiazepin-4(5<i>H</i>)-one

C15H12N2O

Daouda, BalloBihel, FrédéricDoumbia, Mouhamadou LamineEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 8 o2443

a=5.47180(10)Å   b=8.40200(10)Å   c=26.3250(5)Å

α=90.00°   β=90.00°   γ=90.00°

5-Nitro-1,3-bis(prop-2-ynyl)-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one

C13H9N3O3

Kandri Rodi, YoussefMisbahi, KhalidEl-Ghayoury, AbdelkrimZorina, LeokadiyaEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 7 o1159

a=20.0988(16)Å   b=4.2645(3)Å   c=28.669(2)Å

α=90°   β=90°   γ=90°

1-Allyl-3-benzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C17H16N2O

Kandri Rodi, YoussefHaoudi, AmalCapet, FrédéricMazzah, AhmedEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 9 o1477-o1478

a=9.0667(2)Å   b=9.3922(2)Å   c=9.6486(2)Å

α=94.2180(10)°   β=113.5430(10)°   γ=106.2650(10)°